Objective: Intake of fruits and vegetables and levels of serum carotenoids have been associated with decreased risk of stroke, but the results have been inconsistent. The aim of the present study was to examine whether serum concentrations of major carotenoids, ␣-tocopherol and retinol, are related to any stroke and ischemic stroke in men.
of ␣-tocopherol supplementation on incident of ischemic stroke has been much studied, but the results are inconsistent. 15, 16 One possible reason that lycopene might decrease the risk of stroke more than other antioxidants (e.g., ␣-carotene, ␤-carotene, or ␣-tocopherol) may be the consequence of antioxidant activity. Lycopene is a potent antioxidant and the most effective quencher of singlet oxygen, 17 and it was reported to be more effective than ␤-carotene in cell protection against hydrogen peroxide and nitrogen dioxide radicals. 18 Furthermore, different subtypes of stroke have different etiopathologies 19 and thus most likely also have different associations with dietary antioxidants. 14 Ischemic stroke accounts for 85% of all strokes. 20 Oxidative stress through formation of reactive oxygen species (ROS) plays a vital role in mediation of neuronal damage during cerebral ischemia. ROS causes membrane phospholipid disruption and results in ischemic cell injury. 21 The aim of the study was to examine the association of carotenoids retinol and ␣-tocopherol with ischemic stroke and any stroke in men, because there have been only a few previous studies.
METHODS Study population. The analyses were performed with the participants of the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study, a longitudinal populationbased study designed to investigate risk factors for cardiovascular disease, atherosclerosis, and related outcomes. The study population is a representative sample of men living in the city of Kuopio and its surrounding rural communities, who were 42Ϫ61 years of age at baseline. 22 The baseline examinations of the present study were performed between 1991 and 1993. Of 1,229 potentially eligible men, 1,038 (83%) volunteered to participate in baseline examinations, 107 declined to participate, and 52 were not able to participate because of illness, relocation, or death. The participants with no missing data were eligible for the present study. Men with a previous history of stroke (n ϭ 32) were excluded. Concentrations of carotenoids retinol and ␣-tocopherol were available for 1,031 men, who remained in the study.
Standard protocol approvals, registrations, and patient consents. The KIHD Study was approved by the Research Ethics Committee of the University of Kuopio, and each participant gave written informed consent.
Laboratory analyses. Blood specimens were collected in
Terumo Venoject vacuum tubes (10 mL) (Terumo, Tokyo, Japan) from the antecubital vein without tourniquet after an overnight fast. Subjects had rested in a supine position for 30 minutes before blood sampling. Subjects were instructed to abstain from consuming alcohol for 3 days and from smoking for 12 hours before blood collection. Serum for carotenoids and other biochemical measurements was frozen immediately after separation at Ϫ80°C. Concentrations of serum retinol, ␣-tocopherol, and carotenoids were measured by highperformance liquid chromatography (HPLC) as described previously. 23 Mean interassay coefficients of variation varied from 11.0 to 16.2%. Concentrations of serum total, LDL, and highdensity lipoprotein cholesterol and triglycerides were assayed with enzymatic methods as described earlier. 23 Other measurements. Resting blood pressure was measured in the morning by 2 trained nurses with a random-zero mercury sphygmomanometer (Hawksley, Lancing, United Kingdom). After the subjects had rested in a supine position for 5 minutes, 6 measurements were taken at 5-minute intervals: 3 while the subjects were in a supine position, 1 while the subjects were standing, and 2 while the subjects were sitting. The mean of all 6 measurements was used as the systolic blood pressure (SBP) and diastolic blood pressure. Body mass index (BMI) was computed as the ratio of weight (kilograms) to the square of height (meters). Alcohol consumption was assessed with a structured quantity-frequency method on drinking behavior over the previous 12 months. Physical activity was assessed by using a 12month leisure-time history based on self-reported information about frequency per month over the preceding year, average duration per occasion, and intensity level. Metabolic units were Table 1 Characteristics of participants with or without any stroke (n ‫؍‬ 1,031) assigned for each activity according to intensity. 24 Information on diabetes and smoking was collected with a self-administered questionnaire and checked by the interviewer. Diabetes mellitus was defined as a fasting blood glucose level Ն6.7 mmol/L or as a clinical diagnosis of diabetes with dietary, oral, or insulin treatment. A subject was defined as a smoker if he had ever smoked on a regular basis and had smoked cigarettes, cigars, or a pipe within the past 30 days. The lifelong exposure to smoking was estimated as the product of the number of smoking years and the number of tobacco products smoked daily at the time of examination Ascertainment of follow-up events. Incident strokes between 1991 and 1992 were ascertained through the Finnish part of Monitoring of Trends and Determinants in Cardiovascular Diseases (FINMONICA) stroke register. 25, 26 Information on stroke incidence between 1993 and December 31, 1999, was obtained by computerized linkage to the Finnish national hospital discharge registry and death certificate registers. Diagnostic information was collected from hospitals and classified by a neurologist with diagnostic criteria identical to the FINMONICA criteria. The sources of information on stroke were hospital documents, death certificates, autopsy reports, and medicolegal reports. The diagnosis of stroke was based on sudden onset of clinical signs or focal or global disturbance of cerebral function lasting Ͼ24 hours (except in the case of sudden death or if interrupted by surgical intervention) with no apparent cause other than a vascular origin. Each suspected stroke (International Classification of Diseases [ICD]-9 codes 430Ϫ439 and ICD-10 codes I60 -I68 and G45-G46) was classified into 1) a definite stroke, 2) no stroke, or (3) an unclassifiable event. The FIN-MONICA stroke register data were annually rechecked with the data obtained from the computerized national hospital discharge and death registers. Definite strokes and unclassifiable events were included in the group of any stroke. Each definite stroke was classified into 1) an ischemic stroke (ICD-9 codes 433Ϫ434; ICD-10 code I63) or 2) a hemorrhagic stroke (ICD-9 codes 430Ϫ431; ICD-10 codes I60 -I61). If the subject had multiple nonfatal strokes during follow-up, the first stroke was considered as the end point. CT was performed in 90% of the patients by 1993, and CT, MRI, and autopsy reached 100% by 1997. Every resident of Finland has a unique personal identifier that is used in registers. There were no losses to follow-up.
Statistical analysis.
Continuous variables are presented as means (SDs) and categorical variables are presented as percentages. Means of the continuous variables were compared using analysis of variance, and 2 tests were used for categorical variables. The relationship between variables and demographicclinical characteristics associated with serum lycopene were analyzed with Pearson correlation coefficients. Tests of linear trend were conducted by assigning the median values for each category of exposure variable and treating those as a single continuous variable. Subjects were classified into quartiles according to their serum concentrations of antioxidants. Hazard ratios (HRs) and 95% confidence intervals (CIs) for strokes in quartiles of plasma concentrations of antioxidants were analyzed by using a Cox proportional hazards model. Covariates were selected on the basis of their previously established role as a predictive factor on the basis of overall evidence and available data. 10 Thus, risk factors or covariates were chosen based on their clinical relevance. The multivariable-adjusted models included age, examination year, BMI, SBP, smoking, serum LDL cholesterol, diabetes, and history of stroke. Tests for statistical significance were 2-sided, and differences with p Ͻ 0.05 were considered statistically significant. SPSS software (version 19.0; SPSS, Inc., Chicago, IL, USA) was used for statistical analyses.
RESULTS
The median follow-up time to strokes or the end of follow-up was 12.1 years (range 0.03Ϫ13.8 years), 12,475 person-years. There were 50 subjects (4.8%) with ischemic stroke and 67 subjects with any stroke (6.5%). Table 1 shows the baseline characteristics of the subjects. Compared with participants with any stroke, those without any stroke were older, had higher SBP, had lower concentrations of serum lycopene, and had higher incidence of diabetes. Smokers had lower levels of lycopene (p ϭ 0.045), ␣-carotene (p Ͻ 0.001), ␤-carotene (p ϭ 0.001), and ␣-tocopherol (p ϭ 0.002) compared with nonsmokers. Table 2 shows the baseline characteristics of the subjects categorized by quartiles of serum lycopene. Men who had lycopene Ͼ0.22 mol/L, compared with those in the lowest categories, were younger, had lower SBP, smoked less, performed higher physical activity, and had higher concentrations of carotenoids ␣-tocopherol and retinol. Pearson correlation coefficients were calculated to assess the relation between carotenoids and possible risk factors for stroke-associated risk factors. Cases of stroke tended to increase with age (r ϭ 0.07, p ϭ 0.034), SBP (r ϭ 0.10, p ϭ 0.001), and diabetes (r ϭ 0.10, p ϭ 0.001), whereas cases decreased with increasing concentrations of lycopene (r ϭ -0.08, p ϭ 0.017). Carotenoids correlated with each other and with retinol and ␣-tocopherol. Lycopene correlated with ␣-carotene (r ϭ 0.16, p Ͻ 0.001), ␤-carotene (r ϭ 0.25, p Ͻ 0.001), retinol (r ϭ 0.09, p ϭ 0.005), and ␣-tocopherol (r ϭ 0.14, p Ͻ 0.001). ␤-Carotene correlated strongly with ␣-carotene (r ϭ 0.61, p Ͻ 0.001) and retinol with ␣-tocopherol (r ϭ 0.31, p Ͻ 0.001).
Demographic and clinical characteristics associated with serum lycopene were assessed by use of Pearson correlation coefficients. Age, BMI, SBP, Table 3 HRs and 95% CIs of any stroke according to quartiles of carotenoids by using the Cox proportional hazards model in the KIHD Study (n ‫؍‬ 1,031) smoking, and history of stroke were inversely associated with serum lycopene, whereas physical activity was positively associated. Serum concentrations were analyzed from the same men (n ϭ 845) during the 7 years follow-up (1998Ϫ2001) to figure out changes in dietary habits. The concentration of lycopene increased from the baseline (0.16 vs 0.20 mol/L, p Ͻ 0.001). Conversely, ␣-tocopherol and ␤-carotene concentrations remained at the same level, whereas the concentration of retinol decreased (2.12 vs 1.92 mol/L, p Ͻ 0.001). There were no data on concentration of ␣-carotene during the follow-up. Table 3 shows the relation of baseline serum concentrations of carotenoids retinol and ␣-tocopherol to the risk of any stroke, and Table 4 shows the relation to the risk of ischemic stroke. After adjustment for age and examination year, high serum lycopene concentrations decreased the risk of any stroke and ischemic stroke. After multivariable adjustment for age, examination year, BMI, SBP, smoking, serum LDL cholesterol, diabetes, and history of stroke, men in the highest quartile of serum lycopene concentrations as compared with men in the lowest quartile had 55% and 59% lower risks of any stroke and ischemic stroke (HR ϭ 0.45, 95% CI 0.25Ϫ0.95, p ϭ 0.036 for any stroke and HR ϭ 0.41, 95% CI 0.17Ϫ0.97, p ϭ 0.042 for ischemic stroke). The cumulative incidence of any stroke by quartiles of lycopene is shown in the figure. The incidence of any stroke was least in the highest quartile of lycopene. Concentrations of ␣-carotene, ␤-carotene, ␣-tocopherol, and retinol were not related to the risk of strokes.
Quartiles of carotenoids
DISCUSSION In this prospective cohort study, high serum lycopene concentrations may decrease the risk of any stroke and ischemic stroke in men. No association was found with concentrations of ␣-carotene, ␤-carotene, ␣-tocopherol, and retinol and any stroke.
Serum concentrations of ␣-carotene and ␤-carotene of this cohort were roughly similar to those found in Table 4 HRs and 95% CIs of ischemic stroke according to quartiles of carotenoids by using the Cox proportional hazards model in the KIHD Study (n ‫؍‬ 1,031) the Japanese population, 11 whereas lycopene concentrations were at the same level as those found in the population of Taiwan. 12 In the Finnish Botnia Dietary study, it was shown that an 0.82-mg intake of lycopene calculated from 3 days of estimated food records corresponds to 0.31 mol/L as blood levels 27, which is as high as the level in the Japanese population. 11 This study suggests that it is possible in Finland to reach serum lycopene concentrations as high as those in other populations. 11 However, there are no recommendations for intake of carotenoids, because carotenoids are not indicated to be essential nutrients for humans, unlike vitamin A. 28 There are no corresponding data on intake of tomato or tomato-based products in Finland. However, in a multicenter study it was observed that tomato intake varies between 18.4 and 163.6 g/day, corresponding to 0.50Ϫ1.31 mol/L as plasma lycopene. 29 Serum concentrations of lycopene, ␣-carotene, and ␤-carotene were lower among current smokers as has been reported previously. 30, 31 There are only a few previous studies that examined the association between concentrations of blood carotenoids and the risk of any stroke and ischemic stroke. It has been reported that high serum concentrations of lycopene, ␣-carotene, ␤-carotene, and total carotenes were related to lower risk of stroke. 10 -12 Furthermore, previous studies have evaluated associations between dietary intake of fruits and vegetables or carotenoids and the risk of strokes. Most of these studies have observed a protective effect against strokes, [5] [6] [7] [8] [9] but some studies had not. 13, 14, 32 In a metaanalysis, an increased fruit and vegetable intake was associated with a reduced risk of stroke. Results support the recommendations to consume more than 5 servings of fruits and vegetables per day, which is likely to cause a major reduction in strokes. 33 Conflicting findings may be due to difficulties in estimating intake of carotenoids or inadequate food frequency questionnaire data. 34 Although an inverse association between ␣-tocopherol supplementation and stroke has been observed in previous studies, 15 we did not find an association between ␣-tocopherol concentrations and ischemic stroke. Meta-analysis consisting of 9 randomized, placebo-controlled trials ␣-tocopherol increased the risk for hemorrhagic stroke by 22% and reduced the risk of ischemic stroke by 10%. 15 In another meta-analysis of 13 randomized controlled trials, ␣-tocopherol supplementation did not protect from stroke. 16 Consistent with a previous study, 10 the association between retinol and ischemic stroke was not observed. The reason may be that retinol levels are highly regulated and vary only slightly with intake. 35 Studies have reported that lycopene has many bioactive functions. Beside its antioxidant properties, it reduces inflammation, inhibits cholesterol synthesis, improves immune function, 36 -38 and prevents platelet aggregation and thrombosis 39 and thereby may decrease the risk of stroke. Besides lycopene, provitamin A carotenoids (e.g., ␣and ␤-carotene) quench efficiently singlet oxygen and interrupt the propagation of the free radicalϪinitiated lipid peroxidation reaction sequence by quenching peroxyl radicals. 3 Analyses in the present study are based on the baseline measurement of serum carotenoids retinol and ␣-tocopherol. Serum concentrations were analyzed from the same men during the follow-up to clarify changes in dietary habits. We observed that the concentration of lycopene increased during follow-up, but the concentration of retinol decreased. The same HPLC method was used at the baseline and during the follow-up. It is possible that after the diagnosis of stroke men had increased amounts of tomatoes or tomato-based products in their diet, which may explain the increased concentration of lycopene.
The strengths of this study include its prospective population-based design, completed follow-up (no losses), and reliable assessments of incident strokes. A primary limitation is that few stroke cases occurred in this cohort, which limits the statistical power. It was not possible to perform statistical analyses separately for smokers and nonsmokers because of the few cases. Residual confounding may be a potential source of bias in this study, most notably due to the lack of information on dietary behaviors in the participants. Other limitations were that we included variables of smoking at the baseline in the model, but we cannot exclude the possibility of residual confounding due to smoking, e.g., related to change of smoking habits after the baseline. Because blood samples were collected at baseline when all men were stroke-free, these concentrations do not represent any changes made after diagnosis. Therefore, it is impossible to know whether patients had changed their lifestyles and dietary habits by increasing intake of dietary antioxidants after ischemic stroke diagnosis. Information on food and nutrient intake was not included in our cohort.
Results of the present study show that high serum concentrations of lycopene, as a marker of intake of tomatoes and tomato-based products, decrease the risk of any stroke and ischemic stroke in men. Thus, a balanced diet including fruits and vegetables may prevent stroke.
